Ken Paulus signs CEO Action for Diversity & Inclusion pledge
Prime Therapeutics commits to advancing diversity and inclusion efforts in the workplaceMay 6, 2021
“By signing the CEO Action for Diversity & Inclusion pledge, we are committing to promote D&I efforts at work and in the community,” said Paulus. “Fostering a diverse and inclusive workplace creates greater innovation and collaboration, which makes us a stronger company and empowers us to better serve our clients and members.”
The CEO Action for Diversity & Inclusion commitment is driven by a realization that addressing D&I is a societal issue, not a competitive issue. The pledge acknowledges that executives play a key role in positive change. Companies from 85 different industries have taken part in the pledge, and signees are given unique perspective on developing a safe and comfortable work environment for all employees.
Over the past several years, Prime has taken concrete action to advance its D&I journey. Last year, Prime welcomed a new diversity, equity, and inclusion (DEI) director. Working closely with Prime’s employee-led D&I Council, the DEI director focuses on furthering Prime’s D&I efforts. Prime also continues its work in establishing the Prime Together Foundation to address health, racial and other forms of inequity. During its 2020 PrimeCares employee giving campaign, employees raised $203,000 for the Foundation in its inaugural year. In 2021, the D&I Council stood up three new employee resource groups (ERGs) and will continue to expand the number of ERGs as interest emerges.
“Diversity, equity and inclusion are important in our society – and to the present and future of Prime. Launching and enhancing our D&I Council and ERGs reflects how our awareness and commitment have evolved,” said Erin Feigal, chief human resources officer for Prime.
“Prime has made diversity and inclusion a company-wide priority,” said Whitney Harvey, diversity, equity and inclusion director for Prime. “We are focused on hiring diverse talent, opening up opportunities for new and existing ERGs, expanding our D&I Council’s visibility across the organization, launching more education, and continuing to strengthen our reputation as an employer of choice because of our efforts.”
June 2, 2022
Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed…
May 23, 2022
Prime Therapeutics’ MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved…
May 5, 2022
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
EAGAN, Minn. – Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3…